Median Technologies: H1 2026 Financial Communication Calendar

About this update from Median Technologies

SOPHIA ANTIPOLIS, France, January 14, 2026 --( BUSINESS WIRE )--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announces today its H1 2026 financial communication calendar. The Company will participate in upcoming investor events: Allinvest Securities Biomed Forum January 29, 2026 – Paris, France Investor Access Conference April 8-9, 2026– Paris, France TP ICAP Midcap Annual Conference May 6-7, 2026 - Paris, France Portzamparc Mid & Small Caps Conference June 24-25, 2026 - Paris, France Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only. About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20260114920598/en/ Contacts MEDIAN TECHNOLOGIES Emmanuelle Leygues VP, Corporate Marketing & Financial Communications +33 6 10 93 58 88 [email protected] Investors - SEITOSEI ACTIFIN Ghislaine Gasparetto +33 6 85 36 76 81 [email protected] Press – MAARC Bruno Arabian +33 6 87 88 47 26 [email protected] Nicolas Entz +33 6 33 67 31 54 [email protected]

View stock analysis, news, and events for Median Technologies